Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 5.0 | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.54 | 1.72 |
NAV | ₹4235.77 | ₹184.61 |
Fund Started | 25 Sep 1995 | 15 Feb 2007 |
Fund Size | ₹41267.69 Cr | ₹9319.87 Cr |
Exit Load | Exit load of 1% if redeemed within 1 months | Exit load for units in excess of 10% of the investment, 1% will be charged for redemption within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 7.62% | 14.56% |
3 Year | 25.73% | 27.61% |
5 Year | 27.17% | 26.11% |
1 Year
3 Year
5 Year
Equity | 97.52% | 99.43% |
Cash | 2.46% | 0.57% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Fortis Healthcare Ltd. | 3.36% |
BSE Ltd. | 3.06% |
Cholamandalam Financial Holdings Ltd. | 2.47% |
AU Small Finance Bank Ltd. | 2.45% |
Persistent Systems Ltd. | 2.36% |
The Federal Bank Ltd. | 2.35% |
Voltas Ltd. | 2.32% |
Max Financial Services Ltd. | 1.91% |
Power Finance Corporation Ltd. | 1.88% |
Ashok Leyland Ltd. | 1.78% |
Name | Assets |
|---|---|
AU Small Finance Bank Ltd. | 5.59% |
Swiggy Ltd. | 5.23% |
The Federal Bank Ltd. | 5.07% |
L&T Finance Ltd. | 4.89% |
Prestige Estates Projects Ltd. | 4.59% |
BSE Ltd. | 4.04% |
Max Financial Services Ltd. | 4.02% |
Glenmark Pharmaceuticals Ltd. | 3.78% |
Sai Life Sciences Ltd. | 3.30% |
JK Cement Ltd. | 3.19% |
Name | Akshay Sharma | Amit Ganatra |
Start Date | 01 Dec 2022 | 03 Oct 2025 |
Name
Start Date
Description | The scheme aims at long term growth of capital through research based investment approach. The funds will be invested in Equity and equity related instruments ,and there will be an exposure to debt and money market instruments also. | The scheme seeks to generate capital appreciation by investing predominantly in Midcap companies |
Launch Date | 25 Sep 1995 | 15 Feb 2007 |
Description
Launch Date